Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q2 EPS of ($0.74), $0.02 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.